Brief: Avalo Reports Q2 Loss Per Share Of $1.38

Avalo Therapeutics

04/08/2022 13:21

Aug 4 (Reuters) - Avalo Therapeutics Inc  AVTX.O :
    * AVALO REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
AND PROVIDES
BUSINESS UPDATES
    * AVALO THERAPEUTICS INC - QTRLY LOSS PER SHARE $1.38

Source text for Eikon:  ID:nGNX5mcbHB 
Further company coverage:  AVTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))